First Header Logo Second Header Logo

Immunogenicity of high-dose influenza vaccination in patients with primary central nervous system malignancy.

Strowd RE, Russell G, Hsu FC, Carter AF, Chan M, Tatter SB, Laxton AW, Alexander-Miller MA, High K, Lesser GJ. Immunogenicity of high-dose influenza vaccination in patients with primary central nervous system malignancy. Neurooncol Pract. 2018 Aug; 5(3):176-183.

View in: PubMed